Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Revenue

In the fiscal year ending March 31, 2026, Rossari Biotech had annual revenue of 23.96B INR with 15.19% growth. Rossari Biotech had revenue of 6.85B in the quarter ending March 31, 2026, with 18.17% growth.

• Revenue: 23.96B
• Revenue Growth: +15.19%
• P/S Ratio: 1.20
• Revenue / Employee: 44.79M
• Employees: 535
• Market Cap: 28.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	23.96B	3.16B	15.19%
Mar 31, 2025	20.80B	2.50B	13.64%
Mar 31, 2024	18.31B	1.75B	10.55%
Mar 31, 2023	16.56B	1.73B	11.66%
Mar 31, 2022	14.83B	7.74B	109.06%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error